Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy.

about

The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: A systematic review with meta-analysis.Organoruthenium Complexes with C^N Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action.

P2860

Q38983276-D1B1DE51-85A7-4BF8-8496-DDB1CD2D6EC5 Q47784937-44BE54F1-01F0-423F-9AA0-0A5877389EA1

P2860

Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy.

Item

http://www.wikidata.org/entity/Q46029514

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Visualizing clinical predictor ...... myelosuppressive chemotherapy.

@en

Visualizing clinical predictor ...... myelosuppressive chemotherapy.

@nl

type

Item

label

Visualizing clinical predictor ...... myelosuppressive chemotherapy.

@en

Visualizing clinical predictor ...... myelosuppressive chemotherapy.

@nl

prefLabel

Visualizing clinical predictor ...... myelosuppressive chemotherapy.

@en

Visualizing clinical predictor ...... myelosuppressive chemotherapy.

@nl

P1476

Visualizing clinical predictor ...... myelosuppressive chemotherapy.

@en

P2093

Chao Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma.

Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

Colony-stimulating factors in the management of neutropenia and its complications.

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.

Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer.

Symptom clusters in cancer patients with brain metastases.

Breakthrough febrile neutropenia and associated complications in Non-Hodgkin's lymphoma patients receiving pegfilgrastim.

P304

111-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1078155212457806

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kevin Yi-Lwern Yap

Alexandre Chan

P577

2012-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23014897

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy.

about

P2860

P2860

Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921